Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 464
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 131
Infectious Diseases Drugs 121
Central Nervous System Drugs 104
Drug Discovery 102
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Clinical Trials 90
Pharmaceuticals 89
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Infusions and Injectables 31
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,376 Results (Page 54 of 119)
- Relevance
  Sort by

Cryptococcosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
90 Pages
Global

From

€3500EUR$4,234USD£3,130GBP

Hospital Infection Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Product Type

 Report
May 2023
100 Pages
Global

From

€3500EUR$4,234USD£3,130GBP

Anti-Infective Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
108 Pages
Global

From

€3500EUR$4,234USD£3,130GBP

Fungal Keratitis Treatment - Global Strategic Business Report

 Report
May 2026
484 Pages
Global

From

€5181EUR$5,850USD£4,477GBP

Biologic & Biosimilar RA Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Heart Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
35 Pages
Global

From

€1771EUR$2,000USD£1,530GBP

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2025-2033

 Report
September 2025
144 Pages
Global

From

€3541EUR$3,999USD£3,060GBP

Multiple Myeloma Drugs Market Size, Share, Trends and Forecast by Therapy, Drug Type, End User, Distribution Channel, and Region, 2025-2033

 Report
August 2025
119 Pages
Global

From

€3541EUR$3,999USD£3,060GBP

Precision and Personalized Medicine in Pharma - Thematic Intelligence

 Report
June 2023
62 Pages
Global

From

€1727EUR$1,950USD£1,492GBP

Diffuse Large B-cell Lymphoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Follicular Lymphoma Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Mantle Cell Lymphoma Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Non Hodgkin Lymphoma (NHL) Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Treating Chronic Myeloid Leukemia by Phase Market - Global Forecast 2026-2032

 Report
January 2026
196 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

Pomalidomide Capsules Market - Global Forecast 2026-2032

 Report
January 2026
199 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

TKI for Chronic Myeloid Leukemia Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

Treatment of Blastic-Phase CML Market - Global Forecast 2026-2032

 Report
January 2026
185 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

Ibrutinib Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3976EUR$4,490USD£3,436GBP

Multiple Myeloma Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
193 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

Chronic Lymphocytic Leukemia Therapeutics Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3139EUR$3,545USD£2,713GBP

€3488EUR$3,939USD£3,014GBP

2,376 Results (Page 54 of 119)
- 1
- 52
- 53
- 54
- 55
- 56

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.